What question did this study set out to answer?

To estimate total annual direct medical expenditures and average lifetime costs per case for pelvic inflammatory disease (PID) and its primary complications.

March 1, 2000Obstetrics and Gynecology

Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial

View Full Paper

Ask AI

Bookmark

Authors

DRDavid B. ReinNational Opinion Research Center

Discussion

Member takes

Implication

Economic modeling study reports substantial healthcare expenditures for pelvic inflammatory disease, indicating that preventative interventions achieve rapid cost-effectiveness.

Key Points

To estimate total annual direct medical expenditures and average lifetime costs per case for pelvic inflammatory disease (PID) and its primary complications.
Analyzed 3 years of private health insurance claims data to determine per-case and sequelae-specific healthcare expenditures.
Used 3 years of national survey data to calculate incidence and prevalence rates of PID, chronic pelvic pain, and ectopic pregnancy.
Constructed a decision probability model to estimate the expected lifetime medical cost per individual case of PID.
Total direct medical expenditures reached $1.88 billion in 1998, including $1.06 billion for acute PID, $360 million for infertility, $295 million for ectopic pregnancy, and $166 million for chronic pelvic pain.
The expected lifetime direct medical expenditure was $1,167 per PID case, with initial acute PID care accounting for $843 of the total.
Approximately 73% of PID cases did not accrue additional healthcare costs beyond the management of the initial acute infection.

Cite This Study

David B. Rein (2000) studied this question.

synapsesocial.com/papers/6a720e5a2163a0a01bc5ea3b https://doi.org/10.1016/s0029-7844(99)00551-7

View Full Paper

Ask AI

Bookmark

Implication

Economic modeling study reports substantial healthcare expenditures for pelvic inflammatory disease, indicating that preventative interventions achieve rapid cost-effectiveness.

Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial

Discussion

Member takes

Implication

Key Points

Cite This Study

Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider